Results 31 to 40 of about 469,674 (156)

Does high body mass index (>25 kg/m2) or weight (>80 kg) reduce the effectiveness of anti‐D prophylaxis in Rh(D)‐negative pregnant women? A systematic review and meta‐analysis

open access: yesVox Sanguinis, Volume 119, Issue 9, Page 902-911, September 2024.
Abstract Background and Objectives Haemolytic disease of the foetus and newborn (HDFN) occurs when maternal antibodies, often triggered by foetal antigens, destroy foetal and neonatal red blood cells. Factors like antibody strength, quantity and gestational age influence HDFN severity.
C. B. M. Ngan   +2 more
wiley   +1 more source

Brain imaging in children with neonatal cholestatic liver disease: A systematic review

open access: yesActa Paediatrica, Volume 113, Issue 6, Page 1168-1185, June 2024.
Abstract Aim To determine if children with neonatal cholestatic liver disease had concurrent and later findings on brain imaging studies that could be attributed and the cholestasis to contribute to the understanding of the impaired neuropsychological development.
Thora Wesenberg Helt   +6 more
wiley   +1 more source

Estrogen‐mediated coupling via gap junctions in the suprachiasmatic nucleus

open access: yesEuropean Journal of Neuroscience, Volume 59, Issue 7, Page 1723-1742, April 2024.
Our study investigates the influence of estrogen on circadian gene expression rhythms in the suprachiasmatic nucleus (SCN) of female mice. We show that estrogen modulates connexin‐mediated intercellular communication specifically through estrogen receptor beta (ERβ) receptors.
Lina Schlaeger   +6 more
wiley   +1 more source

NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence

open access: yesClinical and Translational Medicine, Volume 14, Issue 2, February 2024.
NCAPH significantly influences luminal A breast cancer progression and affects tumour behaviour and treatment response. GSLA10, a gene signature associated with NCAPH, shows promise in predicting luminal A tumour recurrence, demonstrating efficacy alongside existing models such as Oncotype DX.
Marina Mendiburu‐Eliçabe   +22 more
wiley   +1 more source

Comparison of the Rate of Fetomaternal Hemorrhage in Normal Vaginal and Cesarean Delivery

open access: yesمجله دانشکده پزشکی اصفهان, 2008
BACKGROUND: Prophylaxis of Rh immunization has a critical role in the Rh negative pregnant women for prevention of fetal erythroblastosis. The aim of this study was to evaluate the fetomaternal hemorrhage (FMH) in relation to the delivery mode.
Sima Kadkhodayan   +3 more
doaj  

Enfermedad hemolítica perinatal Perinatal hemolytic disease

open access: yesRevista Cubana de Hematología, Inmunología y Hemoterapia, 2000
La enfermedad hemolítica perinatal (EHPN) es una afección inmunológica aloinmune contra antígenos de origen paterno presentes en los hematíes fetales y del recién nacido. Se han reportado numerosos aloanticuerpos dirigidos contra antígenos eritrocitarios
María del Rosario López de Roux   +1 more
doaj  

Título y concentración de IgG anti D en la enfermedad hemolítica del feto y el recién nacido Anti-D IgG titer and concentration in the hemolytic disease of the fetus and newborn

open access: yesRevista Cubana de Hematología, Inmunología y Hemoterapia, 2000
La predicción prenatal de la enfermedad hemolítica del feto y el recién nacido (EHFRN) y la severidad de esta, por métodos no invasivos, es de gran importancia para la adopción temprana de medidas que eviten o minimicen el daño fetal.
María Elena Alfonso Valdés   +7 more
doaj  

ERYTHROBLASTOSIS AND FETAL GROWTH RETARDATION (IUGR) [PDF]

open access: bronze, 1987
Alistair G.S. Philip, Alison M. Tito
openalex   +1 more source

343 Extreme Prematurity, Fetal Growth Restriction, and Non-Immune Erythroblastosis [PDF]

open access: bronze, 2005
Michael Sherman   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy